revealed a plausible mechanism responsible for tumor angiogenesis, a complex process with clear relevance to tumor progression and metastasis, thus supporting the notion that SNHG15 may be a novel target for clinical treatment for glioma patients. This evidence concerns the gene SNHG15 and neoplasm.